SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Clinical trials for SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC) explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC) trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo challenges standard treatment in major head & neck cancer trial
Disease control Not yet recruitingThis study aims to see if new drug combinations can help people with advanced head and neck cancer live longer. It will compare two experimental treatments against the current standard therapy. About 780 patients whose cancer has returned or spread will participate. The main goal…
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Phase: PHASE3 • Sponsor: Groupe Oncologie Radiotherapie Tete et Cou • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Glowing dye could help surgeons spot hidden cancer
Diagnosis Not yet recruitingThis study is testing if a special dye called Indocyanine Green (ICG) can help surgeons see head and neck cancer tissue more clearly during surgery. The goal is to help remove all the cancer and lower the chance it comes back. About 30 adult patients will receive the dye before t…
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Diagnosis
Last updated Mar 31, 2026 12:12 UTC